Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 1
1990 4
1991 3
1992 6
1993 8
1994 8
1995 6
1996 6
1997 7
1998 7
1999 9
2000 2
2001 9
2002 5
2003 8
2004 12
2005 4
2006 9
2007 11
2008 10
2009 8
2010 10
2011 5
2012 6
2013 10
2014 7
2015 5
2016 8
2017 8
2018 8
2019 7
2020 14
2021 7
2022 5
2023 6
2024 3
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D. Barnes NM, et al. Among authors: villalon cm. Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552. Pharmacol Rev. 2021. PMID: 33370241 Free PMC article. Review.
5-Hydroxytryptamine: a chameleon in the heart.
Saxena PR, Villalón CM. Saxena PR, et al. Among authors: villalon cm. Trends Pharmacol Sci. 1991 Jun;12(6):223-7. doi: 10.1016/0165-6147(91)90556-8. Trends Pharmacol Sci. 1991. PMID: 2048217 Review.
Gender aspects of CGRP in migraine.
Labastida-Ramírez A, Rubio-Beltrán E, Villalón CM, MaassenVanDenBrink A. Labastida-Ramírez A, et al. Among authors: villalon cm. Cephalalgia. 2019 Mar;39(3):435-444. doi: 10.1177/0333102417739584. Epub 2017 Oct 30. Cephalalgia. 2019. PMID: 29082826 Free PMC article. Review.
5-hydroxytryptamine and cardiovascular regulation.
Ramage AG, Villalón CM. Ramage AG, et al. Among authors: villalon cm. Trends Pharmacol Sci. 2008 Sep;29(9):472-81. doi: 10.1016/j.tips.2008.06.009. Trends Pharmacol Sci. 2008. PMID: 19086344 Review.
Wiping Out CGRP: Potential Cardiovascular Risks.
MaassenVanDenBrink A, Meijer J, Villalón CM, Ferrari MD. MaassenVanDenBrink A, et al. Among authors: villalon cm. Trends Pharmacol Sci. 2016 Sep;37(9):779-788. doi: 10.1016/j.tips.2016.06.002. Epub 2016 Jun 21. Trends Pharmacol Sci. 2016. PMID: 27338837 Review.
CGRP inhibitors for migraine prophylaxis: a safety review.
Rivera-Mancilla E, Villalón CM, MaassenVanDenBrink A. Rivera-Mancilla E, et al. Among authors: villalon cm. Expert Opin Drug Saf. 2020 Oct;19(10):1237-1250. doi: 10.1080/14740338.2020.1811229. Epub 2020 Sep 21. Expert Opin Drug Saf. 2020. PMID: 32811190 Free article. Review.
239 results